Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR.

[1]  Donglu Zhang,et al.  Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry Data , 2006, Drug Metabolism and Disposition.

[2]  J. van der Greef,et al.  Screening of Natural Products Extracts for the Presence of Phosphodiesterase Inhibitors Using Liquid Chromatography Coupled Online to Parallel Biochemical Detection and Chemical Characterization , 2003, Journal of biomolecular screening.

[3]  Mingshe Zhu,et al.  Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites. , 2009, Chemico-biological interactions.

[4]  D. Colombo,et al.  A full conformational characterization of 13-ethylprogestogens through theoretical calculations and nuclear magnetic resonance spectroscopy , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  F. Guengerich,et al.  Cytochrome p450 enzymes in the generation of commercial products , 2002, Nature Reviews Drug Discovery.

[6]  Thomas Letzel,et al.  On-line coupling of high-performance liquid chromatography to a continuous-flow enzyme assay based on electrospray ionization mass spectrometry. , 2004, Analytical chemistry.

[7]  I. Wilson,et al.  Hype and hypernation : multiple hyphenation of column liquid chromatography and spectroscopy , 2007 .

[8]  L. Murphy,et al.  Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  J. Gies,et al.  Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.

[10]  N. Vermeulen,et al.  Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants. , 2005, Analytical biochemistry.

[11]  Nico P. E. Vermeulen,et al.  Reversed-phase liquid chromatography coupled on-line to estrogen receptor bioaffinity detection based on fluorescence polarization , 2008, Analytical and bioanalytical chemistry.

[12]  N. Vermeulen,et al.  Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. , 2007, Journal of medicinal chemistry.

[13]  D. Moras,et al.  Overexpression, purification, and crystal structure of native ER alpha LBD. , 2001, Protein expression and purification.

[14]  N. Vermeulen,et al.  Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. , 2008, Chemico-biological interactions.

[15]  J. van der Greef,et al.  Gradient reversed-phase liquid chromatography coupled on-line to receptor-affinity detection based on the urokinase receptor. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[16]  K. R. Marshall,et al.  P450 BM3: the very model of a modern flavocytochrome. , 2002, Trends in biochemical sciences.

[17]  T. Gillespie,et al.  APPLICATION OF BIOCATALYSIS TO DRUG METABOLISM: PREPARATION OF MAMMALIAN METABOLITES OF A BIARYL-BIS-SULFONAMIDE AMPA (α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID) RECEPTOR POTENTIATOR USING Actinoplanes missouriensis , 2006, Drug Metabolism and Disposition.

[18]  H. Irth,et al.  High-performance liquid chromatography-mass spectrometry-based acetylcholinesterase assay for the screening of inhibitors in natural extracts. , 2006, Journal of chromatography. A.

[19]  Yiqing Lin,et al.  Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. , 2008, Analytical chemistry.

[20]  J. van der Greef,et al.  Reversed-phase liquid chromatography coupled on-line to receptor affinity detection based on the human estrogen receptor. , 1996, Analytical chemistry.

[21]  O. Pelkonen,et al.  Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  W. Humphreys,et al.  Metabolite Generation via Microbial Biotransformations with Actinomycetes: Rapid Screening for Active Strains and Biosynthesis of Important Human Metabolites of Two Development-Stage Compounds, 5-[(5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non7-yl-methy , 2008, Drug Metabolism and Disposition.

[23]  F. Arnold,et al.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.

[24]  F. Arnold,et al.  Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. , 2006, Biotechnology and bioengineering.

[25]  N. Vermeulen,et al.  Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. , 2006, Biochemical and biophysical research communications.

[26]  J. Kitawaki,et al.  Estrogen biosynthesis in human liver--a comparison of aromatase activity for C-19 steroids in fetal liver, adult liver and hepatoma tissues of human subjects. , 1984, Endocrinologia japonica.

[27]  H. Lingeman,et al.  Systematic development of an enzymatic phosphorylation assay compatible with mass spectrometric detection , 2005, Analytical and bioanalytical chemistry.

[28]  N. Vermeulen,et al.  On-line Formation, Separation, and Estrogen Receptor Affinity Screening of Cytochrome P450-Derived Metabolites of Selective Estrogen Receptor Modulators , 2006, Drug Metabolism and Disposition.

[29]  K. A. White,et al.  A survey of the high-field 1H NMR spectra of the steroid hormones, their hydroxylated derivatives, and related compounds , 1990 .

[30]  K. Tori,et al.  Conformation of ring A in some 2β-hydroxy- and 2β-acetoxy-Δ4-3-ketosteroids , 1963 .

[31]  J. V. Sancho,et al.  Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation. , 2008, Rapid communications in mass spectrometry : RCM.

[32]  J. Gustafsson,et al.  The Estrogen Receptor β Subtype: A Novel Mediator of Estrogen Action in Neuroendocrine Systems , 1998, Frontiers in Neuroendocrinology.

[33]  H. Irth,et al.  High Resolution Screening of Plant Natural Product Extracts for Estrogen Receptor a and f3 Binding Activity Using an Online HPLC-MS Biochemical Detection System , 2001, Journal of biomolecular screening.

[34]  J. Kitawaki,et al.  Aromatization of norethindrone to ethynylestradiol in human adult liver. , 1986 .

[35]  I. Wiegratz,et al.  Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? , 2007, Climacteric : the journal of the International Menopause Society.

[36]  A. A. Salem,et al.  Application of nuclear magnetic resonance spectroscopy for quantitative analysis of miconazole, metronidazole and sulfamethoxazole in pharmaceutical and urine samples. , 2006, Journal of pharmaceutical and biomedical analysis.

[37]  Arno P M Kentgens,et al.  A microfluidic high-resolution NMR flow probe. , 2009, Journal of the American Chemical Society.

[38]  C. Haasnoot,et al.  Assignment of the 1H and 13C nuclear magnetic resonance spectra of norethisterone using two-dimensional nuclear magnetic resonance spectroscopy , 1984 .

[39]  W. Duax,et al.  Crystalline molecular structures of two derivatives of 2 beta-hydroxytestosterone having an unusual A-ring conformation. , 1971, Journal of medicinal chemistry.

[40]  G. Hopfgartner,et al.  New analytical strategies in studying drug metabolism , 2007, Analytical and bioanalytical chemistry.

[41]  Christensen Hd,et al.  Oxygenated norethindrone derivatives from incubation with beagle liver. Structure, synthesis, and biological activity. , 1974 .

[42]  Johan Hartman,et al.  Estrogen receptor beta in breast cancer—Diagnostic and therapeutic implications , 2009, Steroids.

[43]  Lars Ridder,et al.  SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites , 2008, ChemMedChem.

[44]  Henk Lingeman,et al.  High-temperature liquid chromatography coupled on-line to a continuous-flow biochemical screening assay with electrospray ionization mass spectrometric detection. , 2005, Analytical chemistry.

[45]  Rob Leurs,et al.  A Flow-Through Fluorescence Polarization Detection System for Measuring GPCR-Mediated Modulation of cAMP Production , 2007, Journal of biomolecular screening.

[46]  Hee-Yong Kim,et al.  Determination of steroids by liquid chromatography/mass spectrometry , 1997 .

[47]  Henk Lingeman,et al.  Mass spectrometry-based biochemical assays for enzyme-inhibitor screening , 2007 .

[48]  Swapan Chowdhury,et al.  An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data. , 2009, Analytical chemistry.

[49]  F. Walker,et al.  Structure and stereochemistry of products of hydroxylation of human steroid hormones by a housefly cytochrome P450 (CYP6A1) , 2006, Magnetic resonance in chemistry : MRC.

[50]  G. Kuiper,et al.  Estrogen receptor and the SERM concept , 1999, Journal of endocrinological investigation.